Pediatrics
Outline
The Department of Pediatrics was established in 1972 when Kanazawa Medical University was founded. It was first led by Professor and Chair YOSHIDA Seizo. The second Professor and Chair, Dr. SHIKE Shoichiro, headed the department from 1978, followed by Prof. TAKAHASHI Hiroaki from 1992, and Prof. SAIKAWA Yutaka from 2008. In 2024, Prof. IKAWA Yasuhiro became the fifth Chair and has been leading the department since then.
Clinical sections provide specialized care across all therapeutic areas in the department: hematology and oncology, endocrinology and metabolism, neurology, cardiology, nephrology, allergy, and neonatology.
In the research section, we utilize molecular biological techniques to understand unknown pathological conditions encountered in daily clinical practice and share our findings both domestically and internationally.
e-mail: pediat【a】kanazawa-med.ac.jp（【a】=@）
Faculty
Assistant Professor
TAO Katsuo
Assistant Professor
FUJISAWA Kai
Research Achievements
-
Yasuhiro IkawaEstablishment of Preclinical Trial of Lentiviral Gene Transfer to Prevent Bloom Syndrome-Related Hematological MalignancyDepartment of Pediatrics, Kanazawa Medical University, 2025 March 50(1):15-20
-
Fujisawa Reiko, Mitsui Yoshitaka, Ichinose Mari, Ikawa YasuhitoPiriformis syndrome as a presentation of sacroiliitis with piriformis myositisaccepted on March 12,2025 for publication in Pediatrics International
-
Morikawa M, Yoshizaki H, Yasui Y, Nishida S, Saikawa Y, Kohno M, Okajima HMesenchymal cells regulate enteric neural crest cell migration via RET-GFRA1b trans-signalingBiochem Biophys Res Commun. 2024 May 28;710:149861
-
Yoshitaka Mitsui, Hitoshi Sato, Sumihito Togi, Hiroki Ura, Yo NiidaA case of SCN8A-related developmental epileptic encephalopathy diagnosed by clinical speculation driven targeted DNA
sequencing and remission of epilepsy by sodium channel blockers combination therapyBrain and Development Case Reports. 2024 Jun ;2(2):100015 -
Naoki Okada, Reiko Fujisawa, Yutaka Saikawa, Hitoshi SatoHemophagocytic Lymphohistiocytosis during the Treatment of T-lymphoblastic LymphomaJournal of Kanazawa Medical University. 2024;49(1):35-37
External Research Funding
-
KAKENHI Grants-in-Aid for Scientific Research Apr.1/2025-Mar.31/2027Establishment of a preclinical gene therapy trial to prevent thedevelopment of hematologic tumors for Bloom's syndrome.Principal Investigator: IKAWA, Yasuhiro